These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15591104)

  • 1. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
    Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.
    Patel RA; Glover DK; Broisat A; Kabul HK; Ruiz M; Goodman NC; Kramer CM; Meerdink DJ; Linden J; Beller GA
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H637-42. PubMed ID: 19502555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
    Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3164-71. PubMed ID: 17308004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI.
    Yang Z; Linden J; Berr SS; Kron IL; Beller GA; French BA
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2328-35. PubMed ID: 18849340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy.
    Lange-Sperandio B; Forbes MS; Thornhill B; Okusa MD; Linden J; Chevalier RL
    Nephron Exp Nephrol; 2005; 100(3):e113-23. PubMed ID: 15824514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.
    Reece TB; Kron IL; Okonkwo DO; Laurent JJ; Tache-Leon C; Maxey TS; Ellman PI; Linden J; Tribble CG; Kern JA
    J Vasc Surg; 2006 Aug; 44(2):392-7. PubMed ID: 16890874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.
    Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S
    Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.
    Al-Ayadhi LY; Al-Tuwajri AS
    Pharmacol Res; 2004 Aug; 50(2):157-63. PubMed ID: 15177304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation.
    Riou LM; Ruiz M; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA; Glover DK
    J Am Coll Cardiol; 2002 Nov; 40(9):1687-94. PubMed ID: 12427424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion.
    Cassada DC; Tribble CG; Laubach VE; Nguyen BN; Rieger JM; Linden J; Kaza AK; Long SM; Kron IL; Kern JA
    J Vasc Surg; 2001 Sep; 34(3):482-8. PubMed ID: 11533601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia.
    Cassada DC; Tribble CG; Long SM; Laubach VE; Kaza AK; Linden J; Nguyen BN; Rieger JM; Fiser SM; Kron IL; Kern JA
    J Vasc Surg; 2002 May; 35(5):994-8. PubMed ID: 12021717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease.
    Odashima M; Bamias G; Rivera-Nieves J; Linden J; Nast CC; Moskaluk CA; Marini M; Sugawara K; Kozaiwa K; Otaka M; Watanabe S; Cominelli F
    Gastroenterology; 2005 Jul; 129(1):26-33. PubMed ID: 16012931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping.
    Reece TB; Okonkwo DO; Ellman PI; Maxey TS; Tache-Leon C; Warren PS; Laurent JJ; Linden J; Kron IL; Tribble CG; Kern JA
    Ann Thorac Surg; 2006 Mar; 81(3):902-9. PubMed ID: 16488692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury.
    Reece TB; Laubach VE; Tribble CG; Maxey TS; Ellman PI; Warren PS; Schulman AM; Linden J; Kern JA; Kron IL
    Ann Thorac Surg; 2005 Apr; 79(4):1189-95. PubMed ID: 15797048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
    Auchampach JA; Ge ZD; Wan TC; Moore J; Gross GJ
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H607-13. PubMed ID: 12689858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.
    Cassada DC; Tribble CG; Kaza AK; Fiser SM; Long SM; Linden J; Rieger JM; Kron IL; Kern JA
    Surgery; 2001 Aug; 130(2):230-5. PubMed ID: 11490354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation.
    Reece TB; Ellman PI; Maxey TS; Crosby IK; Warren PS; Chong TW; LeGallo RD; Linden J; Kern JA; Tribble CG; Kron IL
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1137-43. PubMed ID: 15867791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.